AKT1 and cancer: For example, studies have revealed that it can lead to oxaliplatin resistance via activation of the PI3K/Akt pathway in HT-29 cells [29, 30] and contribute to cancer cell progression via the upregulation of ACAT1 [31]; additionally, it can increase proliferation and migration of HCT-116 cells [32].